Decreased levels would be expected to increase tumor cell susceptibility to apoptosis, yet NFE2L2 deficiency may increase the risk of pulmonary metastasis [34] although the significance of decreased expression of the gene in osteosarcoma is not well understood. The gene discussed is NFE2L2; the disease is neoplasm.